Trials / Conditions / BTK Inhibitors
BTK Inhibitors
4 registered clinical trials studyying BTK Inhibitors — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Zanubrutinib and Acalabrutinib Use and Risk of Atrial Fibrillation in Patients With Chronic B-cell Malignancie NCT07283965 | University Hospital, Caen | — |
| Not Yet Recruiting | Zanubrutinib, Chidamide, and Rituximab Induction With or Without CHOP Versus R-CHOP in Newly Diagnosed Double- NCT06890585 | Li Zhiming | Phase 2 |
| Not Yet Recruiting | Zanubrutinib Plus GCVP (Obinutuzumab, Cyclophosphamide, Vindesine, Prednisolone) in Previously Untreated Folli NCT06918015 | Zhejiang Cancer Hospital | Phase 2 |
| Active Not Recruiting | Ibrutinib and Acalabrutinib Use and Risk of Atrial Fibrillation in Patients With Chronic B-cell Malignancies NCT06561243 | University Hospital, Caen | — |